Navigation Links
Back to Basics in Health in Advanced Countries Now
Post Your Comments:
(Date:12/4/2008)...ES, Dec. 4 Jessica Biel and family...ay party held Dec. 2 at the Childrens,Hospital Lo... The Difference,Network, included numerous record...n effort to bring holiday spirit to children at th...rous activities as well as seeing some of the,gre...
(Date:12/4/2008)...revents growing baby from rejecting the mother, re...lthDay News) -- During pregnancy, many of the moth...s that prevent the growing baby from rejecting its...ws that the two coexist by making the fetus, immun...ld lead to new techniques in stem cell treatments ...
(Date:12/4/2008)...Dec. 4 SecureWorks(R), a leading S...seen a 161% increase in the number of,attempted h...lients.,Attempted attacks increased from an avera...x months of the year to 133,000 per client per mon...cs represent the attack activity for 36 major,ret...
(Date:12/4/2008)... Dec. 4, 2008 Use of the drug interferon as a lon...n of liver disease associated with the hepatitis C...ter researchers and their colleagues from nine oth... , Results of the 3-year study, called the HALT-...st Cirrhosis) Trial, appear in today,s issue of T...
Breaking Medicine News(10 mins):Health News:Jessica Biel and Make The Difference Network Bring Holiday Cheer to Childrens Hospital Los Angeles 2Health News:Mom's Cells Prime Fetal Immune System 2Health News:Mom's Cells Prime Fetal Immune System 3Health News:Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks 2Health News:Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks 3Health News:Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks 4Health News:Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks 5Health News:HALT-C researchers: Interferon as long-term treatment for hepatitis C not effective 2
...ed on Thursday that the bird flu is under control ...nt of poultry would be lifted// within days before...he country would stay vigilant against new outbrea...d to remove restrictions imposed after the virus w...
...al of Obstetrics and Gynecology has advocated the ...taminophen for pain relief// after a cesarean sect... better option than patient-controlled morphine. ...tcesarean pain "offers superior pain relief with f...
...rry of Britain has launched an AIDS charity for th... Princess Diana//. The charity's aim is to help ch...sited two years ago. He was there again Friday fo...ich is called "Sentebale", meaning "Forget me not"...
...ard of the hospital raised a furore and apparently...t the doctor conducted himself in an indecent mann...as been totally denied by the Doctor in question. ...ctors at Government Medical College and Hospital t...
Other Medicine News:Health News:Myanmar To Lift Ban On Poultry As Bird Flu Under Control 2
(Date:12/3/2008)...ial in newly diagnosed patients with a life-threat...sessions at ASH , , - Exjade results at ASH...nts by significantly reducing toxic iron that can ...from major independent breast cancer trial at SABC...tegy, Femara vs. tamoxifen , , - Multiple Z...
(Date:12/3/2008)...l/ -- Wyeth Pharmaceuticals,a division of Wyeth ...ted a,marketing authorization application (MAA) t...al to market its investigational 13-valent pneumoc...oung children. Wyeth is seeking an,indication fo...ed by the 13,serotypes included in the investigat...
(Date:12/2/2008)...earchers using functional,MRI (fMRI) have determi...esponsible for suppressing memory is dysfunctional...atric disorders. Results of the study will be pres...ical Society of North America,(RSNA). , "F...-related disorders,traumatic memories are a sour...
(Date:12/2/2008)...herapeutics, Inc., a,privately held biopharmaceut...ase 3 trials evaluating its lead investigational p...nts. HZT-501, a novel, proprietary fixed-dose,com...ne, demonstrated a,statistically significant redu...ammatory drug (NSAID)-induced upper gastrointestin...
Breaking Medicine Technology:More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 2More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 3More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 4More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 5More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 6More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 7More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 8More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 9More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 10More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 11More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 12More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 13More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 14More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 15More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 16More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 17More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 18More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 19More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 20More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 21More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 22Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 2Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 3Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 4Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 5Stress-Related Disorders Affect Brain's Processing of Memory 2Stress-Related Disorders Affect Brain's Processing of Memory 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Cocaine addiction linked to voluntary drug use and cellular memory UCSF study shows 24681 1Cocaine addiction linked to voluntary drug use and cellular memory UCSF study shows 24681 2Tel Aviv University researchers root out new and efficient crop plants 4267 1Tel Aviv University researchers root out new and efficient crop plants 4267 2Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients 24678 1Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients 24678 2Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients 24678 3Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients 24678 4Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients 24678 5Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients 24678 6Escalon 28R 29 Receives FDA 510 28k 29 Clearance to Market the LIASYS 28TM 29 Clinical Chemistry and Immunoturbidimetric Analyzer 24675 1Escalon 28R 29 Receives FDA 510 28k 29 Clearance to Market the LIASYS 28TM 29 Clinical Chemistry and Immunoturbidimetric Analyzer 24675 2Escalon 28R 29 Receives FDA 510 28k 29 Clearance to Market the LIASYS 28TM 29 Clinical Chemistry and Immunoturbidimetric Analyzer 24675 3
...-Apr 10, 2007 - Inotek,Pharmaceuticals Corporation...roke of preclinical animal data showing that the,a...RP) inhibitor,has a large protective effect on the...e. PARP is a nuclear enzyme that directs the,repai...t of DNA,repair enzymes and has potential applicat...
...s Unite to Help Educate on Good,Diabetes Managemen...th Problems, SEATTLE, April 10, 2007 /PRNewswire/ ...lence and cost of type 2 diabetes,complications sh....9 percent) with type 2 diabetes have at least one...ociated with the disease, and,that these health pr...
Other Medicine Technology:Inotek Pharmaceuticals Announces Publication of Animal Data from,Study of PARP Inhibition as Potential Preventative of Brain Injury,Following Stroke 2Inotek Pharmaceuticals Announces Publication of Animal Data from,Study of PARP Inhibition as Potential Preventative of Brain Injury,Following Stroke 3First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 2First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 3First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 4First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 5First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 6First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 7
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
Medicine Products: